Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Enanta Pharmaceuticals (ENTA) EPS (Weighted Average and Diluted): 2011-2025

Historic EPS (Weighted Average and Diluted) for Enanta Pharmaceuticals (ENTA) over the last 15 years, with Sep 2025 value amounting to -$3.84.

  • Enanta Pharmaceuticals' EPS (Weighted Average and Diluted) rose 35.29% to -$0.88 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.84, marking a year-over-year increase of 29.93%. This contributed to the annual value of -$3.84 for FY2025, which is 29.93% up from last year.
  • As of FY2025, Enanta Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$3.84, which was up 29.93% from -$5.48 recorded in FY2024.
  • Enanta Pharmaceuticals' EPS (Weighted Average and Diluted)'s 5-year high stood at -$3.84 during FY2025, with a 5-year trough of -$6.38 in FY2023.
  • In the last 3 years, Enanta Pharmaceuticals' EPS (Weighted Average and Diluted) had a median value of -$5.48 in 2024 and averaged -$5.23.
  • Per our database at Business Quant, Enanta Pharmaceuticals' EPS (Weighted Average and Diluted) slumped by 116.57% in 2021 and then increased by 29.93% in 2025.
  • Enanta Pharmaceuticals' EPS (Weighted Average and Diluted) (Yearly) stood at -$3.92 in 2021, then crashed by 50.77% to -$5.91 in 2022, then dropped by 7.95% to -$6.38 in 2023, then increased by 14.11% to -$5.48 in 2024, then rose by 29.93% to -$3.84 in 2025.